Pale Fire Capital SE Takes $374,000 Position in Tenet Healthcare Corporation $THC

Pale Fire Capital SE acquired a new stake in Tenet Healthcare Corporation (NYSE:THC) during the second quarter, Holdings Channel reports. The fund acquired 2,000 shares of the company’s stock, valued at approximately $374,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at $248,494,000. Wellington Management Group LLP raised its holdings in Tenet Healthcare by 1,114.2% in the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock valued at $225,706,000 after buying an additional 1,042,260 shares during the period. Manning & Napier Advisors LLC acquired a new position in Tenet Healthcare in the second quarter valued at about $168,761,000. Boston Partners boosted its stake in Tenet Healthcare by 38.8% during the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares during the period. Finally, AQR Capital Management LLC increased its position in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other news, Director Tammy Romo sold 2,500 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $260.83, for a total value of $652,075.00. Following the sale, the director directly owned 28,284 shares in the company, valued at approximately $7,377,315.72. This trade represents a 8.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Cecil D. Haney sold 1,300 shares of the business’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $278.03, for a total transaction of $361,439.00. Following the transaction, the director owned 12,553 shares of the company’s stock, valued at approximately $3,490,110.59. The trade was a 9.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 108,037 shares of company stock valued at $28,965,972 over the last quarter. Insiders own 0.97% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on THC shares. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, August 20th. Mizuho set a $290.00 price target on Tenet Healthcare in a research note on Monday, August 10th. Royal Bank Of Canada raised their price target on Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, August 23rd. Finally, UBS Group raised their target price on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Buy” and an average target price of $273.00.

Tenet Healthcare Trading Down 2.7%

NYSE:THC opened at $258.79 on Thursday. The stock has a fifty day moving average price of $234.93 and a 200 day moving average price of $210.62. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $283.05. The firm has a market cap of $20.84 billion, a PE ratio of 9.98, a price-to-earnings-growth ratio of 1.01 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.Tenet Healthcare’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 21.04 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.